Valuation Synlogic, Inc.

Stocks

Market Closed - OTC Markets 22:47:50 16/09/2026 +03			5-day change	1st Jan Change
1.160 ^USD	-0.85%		+0.87%	+3.57%

08-11	Synlogic, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-29	Caldera Therapeutics, Inc. entered into an agreement and plan of merger to acquire Synlogic, Inc. for an enterprise value of approximately $500 million in a reverse merger transaction.	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	75.24	168.7	53.6	35.38	16.37	13.1
Change	-	124.21%	-68.23%	-33.99%	-53.72%	-19.98%
Enterprise Value (EV) ¹	-2.397	52.66	-3.736	4.908	-2.485	-1.565
Change	-	2,296.5%	-107.09%	231.38%	-150.64%	37.02%
P/E	-1.31x	-2.21x	-0.82x	-0.44x	-0.73x	-13.7x
PBR	0.72x	1.15x	0.61x	0.83x	1.28x	1.1x
PEG	-	0.1x	0.1x	0x	0x	0.1x
Capitalization / Revenue	138x	96.2x	45.4x	10.5x	2,047x	-
EV / Revenue	-4.4x	30x	-3.17x	1.46x	-311x	-
EV / EBITDA	0.04x	-0.9x	0.06x	-0.09x	0.16x	0.49x
EV / EBIT	0.04x	-0.87x	0.06x	-0.09x	0.16x	0.44x
EV / FCF	0.09x	-1.75x	0.11x	-0.22x	0.1x	0.29x
FCF Yield	1,054%	-57.1%	885%	-454%	1,042%	345%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-24.77	-16.42	-13.83	-8.81	-1.915	-0.0816
Distribution rate	-	-	-	-	-	-
Net sales ¹	0.545	1.754	1.18	3.371	0.008	-
EBITDA ¹	-57.83	-58.32	-64.9	-53.2	-15.43	-3.185
EBIT ¹	-60.47	-60.76	-67.42	-55.16	-15.78	-3.532
Net income ¹	-59.17	-60.56	-66.15	-57.28	-23.36	-1.005
Net Debt ¹	-77.64	-116	-57.33	-30.47	-18.86	-14.67
Reference price ²	32.400	36.300	11.400	3.850	1.400	1.120
Nbr of stocks (in thousands)	2,322	4,647	4,701	9,189	11,696	11,699
Announcement Date	3/25/21 A	3/17/22 A	3/29/23 A	3/19/24 A	3/6/25 A	3/12/26 A

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
SYNLOGIC, INC.	-	-	-	-	13.69M
LONZA GROUP AG	31.39x	5.65x	16.94x	1.03%	45.81B
REVOLUTION MEDICINES, INC.	-20.96x	242.19x	-22.49x	-.--%	43.91B
IQVIA HOLDINGS INC.	34.73x	3.34x	14.43x	-.--%	44.39B
BEONE MEDICINES AG	45.39x	5.23x	28.64x	-.--%	39.4B
CELLTRION, INC.	26.93x	8.12x	20.58x	0.42%	31.26B
MEDPACE HOLDINGS, INC.	35.28x	5.79x	26.31x	-.--%	17.32B
EUROFINS SCIENTIFIC SE	24.5x	2.13x	9.21x	1.09%	14.73B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	73x	3.87x	15.01x	-.--%	13.03B
Average	31.28x	34.54x	13.58x	0.32%	27.76B
Weighted average by Cap.	26.47x	46.77x	11.96x	0.31%